Michael Triplett

Michael Triplett is a serial life sciences entrepreneur focused on disruptive biotechnology innovations. In addition to Armatus Bio, he serves on several boards, including Clarametyx Biosciences, Neucore Biosciences, Andelyn Biosciences, the NeuroTech Institute, Ohio Life Sciences Association (chair), and InnovateOhio. He previously founded Myonexus Therapeutics, serving as CEO until its acquisition by Sarepta Therapeutics.